Edmond de Rothschild Holding’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-350
| Closed | -$55K | – | 760 |
|
|
2020
Q4 | $55K | Sell |
350
-16,652
| -98% | -$2.62M | ﹤0.01% | 557 |
|
|
2020
Q3 | $1.95M | Buy |
17,002
+2,505
| +17% | +$287K | 0.08% | 201 |
|
|
2020
Q2 | $1.63M | Buy |
14,497
+5,600
| +63% | +$628K | 0.07% | 201 |
|
|
2020
Q1 | $799K | Buy |
+8,897
| New | +$799K | 0.04% | 230 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 612 |
|
|
2018
Q3 | – | Sell |
-250
| Closed | -$31K | – | 769 |
|
|
2018
Q2 | $31K | Hold |
250
| – | – | ﹤0.01% | 631 |
|
|
2018
Q1 | $28K | Hold |
250
| – | – | ﹤0.01% | 671 |
|
|
2017
Q4 | $30K | Buy |
+250
| New | +$30K | ﹤0.01% | 673 |
|
|
2017
Q3 | – | Sell |
-335
| Closed | -$41K | – | 851 |
|
|
2017
Q2 | $41K | Hold |
335
| – | – | ﹤0.01% | 658 |
|
|
2017
Q1 | $41K | Hold |
335
| – | – | ﹤0.01% | 652 |
|
|
2016
Q4 | $41K | Buy |
+335
| New | +$41K | ﹤0.01% | 659 |
|